❌

Normal view

Received today β€” 7 October 2026 ⏭

SPTLC2-driven sphingolipid reprogramming of neutrophils impairs anti-tumour immunity and drives liver cancer progression

βœ‡Oncogene - Issue - nature.com science feeds
By: Zhe Yang Β· Yun Wang Β· Jianhao Li Β· Zishuo Wang Β· Jianan Chen Β· Ding Zhang Β· Guorui Zhao Β· Liwen Liu Β· Zhibo Liu Β· Ning Wang Β· Ranran Sun
28 September 2026 at 08:00

Oncogene, Published online: 28 September 2026; doi:10.1038/s41388-026-03996-2

SPTLC2-driven sphingolipid reprogramming of neutrophils impairs anti-tumour immunity and drives liver cancer progression
There are no more articles
❌